Before testing everyone’s eyes, we must first test our SmartERG™ “R” in the real world. We want to provide our technology to eye researchers to evaluate in the clinic and in the laboratory. We are seeking those researchers ready to assess how our SmartERG™ can be used in the early detection of retinal diseases and neurological conditions such as:
Macular Degeneration, Glaucoma, Diabetic Retinopathy, Retinitis Pigmentosa, and Novel Applications Like Alzheimer’s.